J. Wernicke

537 total citations
10 papers, 424 citations indexed

About

J. Wernicke is a scholar working on Pharmacology, Neurology and Experimental and Cognitive Psychology. According to data from OpenAlex, J. Wernicke has authored 10 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 2 papers in Neurology and 2 papers in Experimental and Cognitive Psychology. Recurrent topics in J. Wernicke's work include Treatment of Major Depression (4 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). J. Wernicke is often cited by papers focused on Treatment of Major Depression (4 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). J. Wernicke collaborates with scholars based in United States, Germany and United Kingdom. J. Wernicke's co-authors include Jay B. Cohn, A. Carlo Altamura, Stuart Montgomery, Bruce E. Dornseif, Janet H. Potvin, Yili Pritchett, Timothy R. Smith, Deborah N. D’Souza, Smriti Iyengar and Joel Raskin and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Pain and Journal of Crohn s and Colitis.

In The Last Decade

J. Wernicke

7 papers receiving 391 citations

Peers

J. Wernicke
Julie Cole United States
André Nayer Belgium
John Guarino United States
M Ferreri France
Josef Schöpf Switzerland
G Beaumont United Kingdom
I. Zieleniuk France
Dale R. Grothe United States
Octavian Vasiliu Romania
Anita Murthy United States
Julie Cole United States
J. Wernicke
Citations per year, relative to J. Wernicke J. Wernicke (= 1×) peers Julie Cole

Countries citing papers authored by J. Wernicke

Since Specialization
Citations

This map shows the geographic impact of J. Wernicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Wernicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Wernicke more than expected).

Fields of papers citing papers by J. Wernicke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Wernicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Wernicke. The network helps show where J. Wernicke may publish in the future.

Co-authorship network of co-authors of J. Wernicke

This figure shows the co-authorship network connecting the top 25 collaborators of J. Wernicke. A scholar is included among the top collaborators of J. Wernicke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Wernicke. J. Wernicke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
Raskin, Joel, Timothy R. Smith, Yili Pritchett, et al.. (2006). Duloxetine versus Routine Care in the Long-Term Management of Diabetic Peripheral Neuropathic Pain. Journal of Palliative Medicine. 9(1). 29–40. 82 indexed citations
4.
Detke, Michael J., Satish Iyengar, Judith Henck, et al.. (2006). Cardiovascular Effects of Duloxetine: Preclinical and Clinical Findings. 3(3). 407–408. 3 indexed citations
5.
Wernicke, J., A. Rosen, Yifei Lü, et al.. (2004). Antidepressants. Journal of Pain. 5(3). S48–S48. 10 indexed citations
6.
Dornseif, Bruce E., et al.. (1990). Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.. PubMed. 26(2). 173–80. 54 indexed citations
7.
Cohn, Jay B., et al.. (1989). A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder. International Clinical Psychopharmacology. 4(4). 313–322. 210 indexed citations
8.
Altamura, A. Carlo, Stuart Montgomery, & J. Wernicke. (1988). The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of Depression. The British Journal of Psychiatry. 153(S3). 109–112. 64 indexed citations
9.
Wernicke, J., et al.. (1984). [Endoscopic aspects of malignant non-Hodgkin lymphomas of the stomach].. PubMed. 22(10). 563–72. 1 indexed citations
10.
Wernicke, J. & C. Schirren. (1983). [Morphological differentiation of human spermatozoa using pre-prepared methods. Comparative studies].. PubMed. 14(6). 471–80.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Cole Breakdown of academic impact, for papers by André Nayer Breakdown of academic impact, for papers by John Guarino Breakdown of academic impact, for papers by M Ferreri Breakdown of academic impact, for papers by Josef Schöpf Breakdown of academic impact, for papers by G Beaumont Breakdown of academic impact, for papers by I. Zieleniuk Breakdown of academic impact, for papers by Dale R. Grothe Breakdown of academic impact, for papers by Octavian Vasiliu Breakdown of academic impact, for papers by Anita Murthy
Rankless by CCL
2026